January 02, 2014
1 min read
Save

Cardiology Today Editorial Board members vote on top 10 stories of 2013

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The following are the Top 10 stories of 2013 in the field of cardiology, as selected by members of the Cardiology Today Editorial Board.

The editors of Cardiology Today value your opinion. Let us know what you think of the 2013 Top 10 list in the comments below.

  1. New 2013 CV risk and treatment guidelines from ACC, AHA and The Obesity Society
  2. Growing excitement surrounding the benefits of renal denervation for resistant hypertension and other issues
  3. Continued enthusiasm about PCSK9 inhibitors
  4. HPS2-THRIVE study: Niacin therapy not beneficial for vascular disease
  5. AMA recognizes obesity as a disease state
  6. How to best position the novel oral anticoagulants for the right patients
  7. Mounting data on the Watchman device as a promising treatment for stroke prevention in atrial fibrillation
  8. MitraClip approved by the FDA
  9. Much-anticipated results from the TOPCAT trial of aldosterone antagonist in HFpEF
  10. CORAL study: Renal stenting failed to reduce clinical events vs. medical therapy